Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.2920
-0.0233 (-7.39%)
At close: Apr 1, 2025, 4:00 PM
0.2965
+0.0045 (1.54%)
After-hours: Apr 1, 2025, 4:24 PM EDT
CLRB's stock price has decreased by -92.16% in the past year and price targets may not have had time to catch up.
Cellectar Biosciences Analyst Ratings
Total Analysts
2
Consensus Rating
Buy
Price Target
$28.00
Upside
+9,489.04%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Oppenheimer | Oppenheimer | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Dec 11, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +4,009.59% | Nov 19, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $14 | Buy | Reiterates | $14 | +4,694.52% | Oct 11, 2024 |
Roth MKM | Roth MKM | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +9,489.04% | Mar 28, 2024 |
Oppenheimer | Oppenheimer | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +4,009.59% | Mar 28, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +6,749.32% | Mar 4, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $3 → $4 | Strong Buy | Maintains | $3 → $4 | +1,269.86% | Nov 4, 2022 |
Oppenheimer | Oppenheimer | Buy Initiates $55 | Buy | Initiates | $55 | +18,735.62% | Jul 18, 2022 |
Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +17,023.29% | Jul 1, 2020 |
Maxim Group | Maxim Group | Strong Buy Initiates $30 | Strong Buy | Initiates | $30 | +10,173.97% | Jun 23, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +34,146.58% | Jan 21, 2020 |
Roth Capital | Roth Capital | Strong Buy Initiates $110 | Strong Buy | Initiates | $110 | +37,571.23% | Sep 13, 2019 |
Ladenburg Thalmann | Ladenburg Thalmann | Strong Buy Initiates $270 | Strong Buy | Initiates | $270 | +92,365.75% | Dec 21, 2016 |